Additionally, Javidroozi et al. (11) reported that plasma dipeptidyl peptidase-4 (DPP4) levels were significantly lower in patients with cancers such as colorectal or liver cancer than in healthy subjects. This evidence concerns the gene DPP4 and cancer.